Oxipen

Quick links to important sections

Oxipen

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Oxipen

Property Description
Active Ingredient Oxacillin (as Sodium Salt)
Form Powder for Injection, Capsule, Oral Suspension
Pharmacological Class Penicillin Antibiotic, Antistaphylococcal
General Purpose Treating bacterial infections caused by resistant bacteria
Origin Semisynthetic

What Type of Medicine is Oxipen?

Oxipen is classified as a prescription-only medicine and is a type of antibiotic belonging to the Penicillin Group of anti-infective drugs. Its core active component, Oxacillin, is a Penicillinase-Resistant Penicillin. The drug is of semisynthetic origin, created through chemical modification of the natural penicillin structure to enhance its therapeutic properties for addressing pathogens resistant to older penicillins.

Composition and Specialized Function

The preparation contains Oxacillin as its active ingredient, frequently in the form of Oxacillin Sodium to ensure optimal delivery. Oxipen functions as an antistaphylococcal penicillin, a specialized type engineered to counteract the bacterial enzyme penicillinase (or beta-lactamase) that typically neutralizes common penicillins. The structure of Oxacillin is designed to maintain stability against this enzyme. Its general therapeutic purpose is to clear severe or persistent bacterial infections, such as those impacting the skin or soft tissues, caused by penicillin-resistant Staphylococcus species.

Available Forms of Oxacillin

Oxacillin is supplied in several dosage forms tailored to patient needs. It is often provided as a powder for injection that is reconstituted into an injectable solution for parenteral delivery (Intramuscular or Intravenous) in acute cases. For continued care or less acute management, the drug may also be formulated as a capsule or an oral suspension. The availability of the oral suspension form specifically broadens its use to the pediatric patient group, ensuring flexible treatment options based on the severity of the infection and the patient’s age.

Regulatory References

  1. U.S. National Library of Medicine
  2. MedlinePlus Drug Information for Oxacillin
  3. DailyMed Label for Oxacillin

What side effects are possible with Oxipen?

Possible Side Effects and Safety Information

The safety profile of Oxipen (Oxacillin) is structured around adverse reactions affecting major physiological systems, as documented in official regulatory labels.

Common Adverse Reactions and System Groupings

Adverse effects are grouped by the body systems involved, including the Gastrointestinal system (e.g., nausea, vomiting, diarrhea), the Dermatologic system (manifesting as skin rash and pruritus), and the Hematologic system (e.g., eosinophilia). Reactions at the injection site may also occur with parenteral administration.

Serious and Significant Reactions

Official documents list several serious adverse reactions. These include severe, immediate hypersensitivity reactions, such as Anaphylaxis. Gastrointestinal complications include Pseudomembranous Colitis or Clostridium difficile-associated diarrhea (CDAD). Renal effects may include Interstitial Nephritis, and severe blood disorders like Neutropenia and Agranulocytosis are also documented.

Safety Considerations and Restrictions

Use of Oxipen is absolutely restricted (contraindicated) for individuals with a known history of hypersensitivity to any penicillin drug. Safety notes address special populations, including the need for periodic liver function monitoring in patients with pre-existing liver disease. Transient hepatic dysfunction has been reported with increased frequency in infants and children. Furthermore, severe hematologic abnormalities are specifically associated with prolonged therapy, particularly when administration exceeds two weeks.

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory documentation for Oxipen (Oxacillin) outlines specific clinical manifestations and required immediate actions in cases of drug accumulation or suspected overdose.

Manifestations and Risks Officially Documented Statement
Documented Manifestations Neurotoxic reactions are observed, including seizures, delirium, and potentially persistent coma. Signs of organ toxicity, such as hepatotoxicity (e.g., elevated SGOT) and interstitial nephritis, may also occur.
Severe Outcomes Serious, occasionally fatal hypersensitivity reactions (anaphylaxis) are documented, which can escalate rapidly to include vascular collapse and death.
High-Risk Factors Patients with renal insufficiency (impaired kidney function) are at greater risk for neurotoxic reactions, especially with large intravenous doses, requiring consideration of dosage adjustment and blood level monitoring.

Emergency Response and Management Officially Documented Statement
Required Action It is officially mandated to seek immediate medical attention for any suspected overdose. For life-threatening symptoms, such as collapse or seizure, instructions require calling emergency services (911) or Poison Control.
Management Overdose management involves the institution of symptomatic and supportive treatment. The official documentation states that no specific antidote is known for Oxacillin overdose.

The regulatory profile strictly defines when urgent care must be sought: any sign of severe neurotoxicity, organ dysfunction, or immediate hypersensitivity requires prompt medical intervention. Supportive care is the primary approach for managing these documented overdose scenarios.

Therapeutic Uses of Oxipen

What Oxipen Treats: Main Uses and Benefits

Oxipen is commonly used in conditions presenting with systemic or localized discomfort caused by certain resistant bacteria. This medication is applied across domains where additional symptomatic support is needed, and is often used during phases when symptoms become more noticeable.

Oxipen is commonly used across conditions presenting with acute episodes caused by resistant bacteria, including conditions such as bacteremia (blood infection), osteomyelitis (bone infection), valvular endocarditis (heart lining infection), and severe skin and soft tissue infections. The primary therapeutic benefit assists in addressing the overall symptom load associated with these organisms, which is relevant in contexts involving heightened systemic burden.

The medication supports the patient during symptomatic periods by easing the overall symptom load, helping to address symptom clusters that may become intense or disruptive, specifically high fever, generalized malaise, and localized pain and swelling in the affected tissues. This provides supportive relief when symptoms interfere with routine activities, contributing to improved comfort during periods of heightened symptoms.


Quick Fact: Relief for Systemic Discomfort

Oxipen is generally used for conditions marked by increased physiological stress, and helps to manage systemic symptoms (like fever) alongside localized inflammatory distress (like swelling and pain), assisting with maintaining functional stability.

Regulatory References

  1. DailyMed official label for Oxacillin

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Oxipen — Official Regulatory Information


Eligibility Scope

Population Group Regulatory Status Restriction Context
Contraindicated Absolute Prohibition History of hypersensitivity (including anaphylaxis) to any penicillin or Oxacillin itself.
Pediatric Patients Use Established Monitoring for renal impairment is advised in neonates [Source: DailyMed/FDA].
Geriatric Patients Caution Required Greater likelihood of decreased renal function in this age group [Source: DailyMed/FDA].
Renal Impairment Conditional Use If impairment is known, blood levels must be monitored to avoid neurotoxic reactions [Source: DailyMed/FDA].
Hepatic Impairment Conditional Use Periodic assessment of liver function is required during prolonged therapy [Source: DailyMed/FDA].
Pregnant Women Conditional Use Should be used only if clearly needed; classified as Pregnancy Category B in older labeling [Source: DailyMed/FDA].
Nursing Mothers Caution Required Penicillins are excreted in human milk [Source: DailyMed/FDA].
Allergies/Asthma Conditional Use Use with caution in individuals with histories of significant allergies or asthma [Source: DailyMed/FDA].

Eligibility Classifications (High-Level)

  • Eligibility severity classification: Absolute Contraindication (Hypersensitivity), Conditional Use/Caution Required (Organ Function, Age, Pregnancy, Lactation).
  • Regulatory basis: U.S. Food and Drug Administration (FDA) Prescribing Information / DailyMed.

Resulting Eligibility Structure

Official eligibility statements:

  • Oxipen is absolutely prohibited for patients with a history of sensitivity to any penicillin.
  • Use in the geriatric population must be approached with caution due to potential physiological changes.
  • Use during pregnancy is restricted to cases where the medicine is clearly needed.

Connection to the overall eligibility profile: Regulatory documents define eligibility by imposing an absolute contraindication for patients with any known penicillin hypersensitivity. For other populations, eligibility is defined through conditional use constraints, requiring caution and monitoring based on physiological states like impaired organ function, age, or pregnancy.

What should I know about interactions with other medicines?

Interaction Map: Interactions with other medicines and products — official regulatory information for Oxipen

Interaction Scope

Medicinal product categories with documented interactions include Bacteriostatic Antibiotics, Uricosuric Agents, Vitamin K Antagonists, and Live Bacterial Vaccines. Specific interacting medicines explicitly listed in official documents include Probenecid, Tetracyclines, and Warfarin. The mechanistic basis for some interactions involves the inhibition of renal tubular secretion or pharmacodynamic antagonism. A key timing-based interaction rule for the oral form requires administration one hour before or two hours after meals to prevent reduced absorption. Co-administration with specific live bacterial vaccines is formally contraindicated.


Interaction Classifications (High-Level)

Interaction severity classification includes Contraindicated (for live vaccines), Avoided (for bacteriostatic agents), and Clinically significant (for Probenecid, Warfarin, and Food). The regulatory basis for these classifications is derived from authorities such as the FDA. A specific timing constraint applies to the oral dosage form when administered with food.


Resulting Interaction Structure

Official interaction statements:

  • Probenecid prolongs the elimination of Oxipen by blocking its renal tubular secretion, thereby increasing the drug's serum concentration.
  • Co-administration with Tetracyclines should be avoided, as the bacteriostatic agent may antagonize the intended bactericidal effect.
  • Concomitant use with Vitamin K Antagonists (e.g., Warfarin) may result in an increase in the anticoagulant effect of those medicines.
  • The use of Oxipen is contraindicated with Cholera Vaccine, Live and Typhoid Vaccine, Live (Ty21a strain) due to the potential for decreased vaccine effectiveness.
  • Administration of the oral formulation with food results in reduced absorption, necessitating a required time separation from meals.

Mechanism of Action

Inhibition of Bacterial Cell Wall Construction

Oxacillin functions by selectively and irreversibly inhibiting bacterial Penicillin-Binding Proteins (PBPs), key enzymes responsible for the final steps of peptidoglycan cross-linking. This covalent molecular binding halts the construction of the rigid bacterial cell wall. The ensuing loss of structural integrity causes the bacterial cell to rupture due to internal osmotic pressure; this process constitutes the bactericidal effect.


Overcoming Bacterial Beta-Lactamase Defense

A specialized feature of the Oxacillin molecule is its inherent resistance to beta-lactamase (penicillinase), a common bacterial enzyme used to inactivate many standard penicillins. Oxacillin's resistance to this enzymatic destruction allows the drug to maintain its active form, facilitating the concentration required to inhibit PBP targets and initiate the cell lysis cascade.


Constraint via Altered Target Affinity

  • The mechanism of action is constrained against resistant strains like MRSA because they express an altered target enzyme, PBP2a. This modified PBP has a significantly low affinity for Oxacillin, which prevents the necessary covalent bond formation. The failure to bind PBP2a means the cell wall synthesis inhibition step is bypassed, indicating that the mechanism of action is non-functional against these specific pathogens.

Dosage and Administration Information

How to Use Oxipen: Administration Guidelines

Oxipen (Oxacillin) is administered using a time-dependent, divided-dose protocol, requiring administration multiple times per day to maintain consistent therapeutic levels.


Administration Routes and Forms

Oxipen is utilized via Parenteral (Intravenous [IV] or Intramuscular [IM] injection) and Oral routes. The choice between routes is often based on the severity of the condition being addressed. For acute or severe infections, the injectable form is typically used. Oral forms, such as capsules or suspensions, are generally used for less severe infections or for maintenance therapy.


Dosing and Scheduling

The standard adult dosing range for Oxipen for severe infections is typically 1 to 2 grams (g), administered every 4 to 6 hours. For less severe, localized infections managed orally, the dose is often 500 milligrams (mg) to 1 g, also administered every 4 to 6 hours. Pediatric dosing (for patients under 40 kg) is calculated according to the child’s body weight, usually ranging from 100 to 200 mg/kg/day in equally divided doses. Dose adjustments are generally not required for patients with mild to moderate kidney impairment.


Contextual Use Instructions

Oral Administration: To ensure proper absorption, oral Oxipen should be taken on an empty stomach, meaning administration occurs, for example, one hour before or two hours after a meal.

Parenteral Administration: The powder for injection requires reconstitution and subsequent dilution before administration. Intravenous doses are typically infused slowly over a period of 30 to 60 minutes, or given via a direct injection over about 10 minutes. The medicine must not be physically combined with other agents in the same syringe or IV container.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Oxipen

This overview describes the research that has been conducted on Oxipen (Oxacillin), detailing the types of studies that exist and what has been measured, according to official regulatory and scientific sources. This information is for context only and does not contain clinical guidance.


Evidence for Use in Severe/Deep-Seated Infections

Research focusing on Oxipen's use in patients with severe, deep-seated bacterial infections—such as bloodstream infections (bacteremia), heart lining infections (infective endocarditis), and bone infections (osteomyelitis)—has been explored through multiple study designs. This evidence base includes Randomized Controlled Trials (RCTs) that often compare Oxipen to other similar medicines or evaluate different ways of delivering the injection. These studies monitored key measurements, including the evaluation of microbiological status and studies monitoring patient status over defined time intervals, typically up to 90 days.


Evidence for Use in Skin and Soft Tissue Infections (SSTIs)

Research exploring Oxipen in the context of severe or persistent Skin and Soft Tissue Infections (SSTIs) caused by susceptible bacteria relies more heavily on observational cohort studies and clinical case series. These studies focused on measurements of clinical success, which was defined by the resolution of localized signs and symptoms. Research so far indicates patterns where measured outcomes related to symptom evolution and changes in infection markers were commonly reported in the short-term treatment period.


What is Still Uncertain about Oxipen Research

While Oxipen is a long-established medicine, research indicates several areas where data remain limited or inconsistent. These include:

  1. Comparative Evidence: Scientific literature notes that the comparative evidence is lacking in large-scale RCTs that directly pit Oxipen against all of its main therapeutic alternatives for every major deep-seated infection.
  2. Study Sample Size: For some specific indications, the sample sizes were modest, meaning the results apply only to the specific, limited populations studied.
  3. Long-Term Data: There is limited information for long-term outcomes that track patients for extended periods to monitor for long-term patterns of recurrence, especially beyond the 90-day follow-up common in acute infection trials.

Research provides context but not individual predictions. Findings describe group patterns, and research does not determine whether an individual will respond similarly.

Key Studies & References

  1. Label: OXACILLIN injection, powder, for solution - DailyMed
  2. Adverse reactions to oxacillin in hospitalized children: a prospective study

Frequently Asked Questions (FAQ)

Common questions about Oxipen (FAQ)

Q: Are there differences in effectiveness between the pill form and other available forms of Oxipen?

Official labeling indicates that the form of Oxipen used is generally chosen based on the severity of the infection. Injectable forms (IV/IM) are typically used for acute or more severe cases to achieve rapid, high concentrations.

Oral forms (capsules or suspensions) are generally reserved for less severe infections or for maintenance therapy. This distinction in use reflects the need for varying speeds and levels of medicine delivery, as described in official documents.

Q: How long does it usually take for a person to notice the expected effects of Oxipen?

For intravenous administration, the medicine reaches its highest concentration in the bloodstream very quickly, often within approximately five minutes.

Official patient information indicates that some patients may report improvement in symptoms during the first few days of treatment. The full effect requires completing the prescribed course of therapy.

Q: What is the usual recommended duration of use for Oxipen?

The duration of treatment is highly variable and depends entirely on the type and severity of the specific bacterial infection being addressed. For some severe staphylococcal infections, official prescribing information may describe a minimum of 14 days of therapy.

The exact duration is based on an evaluation of the patient's clinical status and response to treatment, as noted in regulatory materials.

Q: Is it necessary to continue using Oxipen even after symptoms begin to improve?

Official patient information generally emphasizes that the entire prescribed course of therapy is intended to be completed, even if symptoms improve quickly or disappear entirely.

Completing the full course of medicine is described as important for fully eliminating the infection and is one factor in potentially reducing the development of drug-resistant bacteria.

Q: What happens if a patient misses a dose of Oxipen?

Official instructions emphasize the importance of avoiding missed doses to help ensure the full course of therapy is completed and to maintain consistent drug levels.

If a dose is missed, patients are specifically advised in patient information against taking extra medicine to make up for the missed amount.

Q: Does taking Oxipen at a certain time of day affect how the medicine works?

The critical factor in dosing is maintaining consistent therapeutic levels in the body, which is essential for the drug’s effectiveness. Regulatory documents specify that the medicine must be administered multiple times a day (such as every 4 to 6 hours) to achieve this consistent concentration.

The required frequency is based on the drug's properties rather than a specific time of day.

Q: How often were common side effects reported in the initial research studies for Oxipen?

Official documents often group adverse reactions by incidence rates but may not provide specific percentage data in general patient-facing materials. This level of detail is typically found in the full prescribing information for healthcare professionals.

For example, clinical literature has noted reported incidences of allergic reactions to penicillin-class medicines, which gives general context for this class of drug.

Q: What common over-the-counter medicines or supplements are described as potentially interacting with Oxipen?

Official drug interaction checkers indicate that some common over-the-counter agents may have documented interactions with Oxipen. This includes medicines like Acetaminophen (Paracetamol) and Acetylsalicylic Acid (Aspirin).

These particular interactions are generally noted in regulatory sources for awareness.

Q: Does Oxipen interact with common vitamins or herbal remedies like St. John's Wort?

Regulatory screening has noted that some vitamins and herbal supplements are described as having documented effects on the concentration or processing of Oxipen by the body.

For example, supplements such as Ginkgo Biloba and certain Multivitamins are noted in drug interaction check systems.

Q: Are there any known drug-condition interactions for people with high blood pressure or heart conditions?

Regulatory documents carry a specific caution for patients with pre-existing conditions like high blood pressure or heart failure. This caution is due to the fact that Oxacillin contains sodium (salt), a factor that is noted in official documents for awareness when sodium intake is restricted.

Q: Does taking multiple medications with Oxipen increase the potential for a known interaction?

Regulatory documents describe a limited number of specific, clinically relevant interactions. Because many substances are processed by the body’s excretory organs, taking multiple medications is noted as a factor that may affect Oxipen’s concentration or effectiveness.

For this reason, patient monitoring is often required during prolonged therapy when multiple drugs are used concomitantly.

How should Oxipen be stored and disposed of?

How to Store and Dispose of Oxipen?

The storage requirements for Oxipen (Oxacillin) are strictly regulated and depend on the product form. The dry powder for injection must be stored at Controlled Room Temperature (20 C to 25 C). Once reconstituted, stability is temperature-dependent: the solution is stable for up to 7 days under refrigeration (2 C to 8 C) or approximately 4 days at room temperature.

Commercially frozen solutions must be thawed at room temperature or refrigerated; do not force thaw. Solutions that appear cloudy or contain precipitate must be discarded. The medicine must be kept out of the sight and reach of children.

Disposal of unused or expired product must be carried out according to local regulatory requirements, often utilizing a drug take-back program. This medication should not be flushed down the toilet unless specifically instructed by the label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Oxipen found in:

A-Z Index: